Cargando…

Population-based serology reveals risk factors for RSV infection in children younger than 5 years

Respiratory syncytial virus (RSV) infection is a leading cause of hospitalization in infants. Underlying risk factors for RSV infection in the general population are not well understood, as previous work has focused on severe outcomes of infection in a clinical setting. Here we use RSV-specific IgG...

Descripción completa

Detalles Bibliográficos
Autores principales: Andeweg, Stijn P., Schepp, Rutger M., van de Kassteele, Jan, Mollema, Liesbeth, Berbers, Guy A. M., van Boven, Michiel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076290/
https://www.ncbi.nlm.nih.gov/pubmed/33903695
http://dx.doi.org/10.1038/s41598-021-88524-w
_version_ 1783684667582447616
author Andeweg, Stijn P.
Schepp, Rutger M.
van de Kassteele, Jan
Mollema, Liesbeth
Berbers, Guy A. M.
van Boven, Michiel
author_facet Andeweg, Stijn P.
Schepp, Rutger M.
van de Kassteele, Jan
Mollema, Liesbeth
Berbers, Guy A. M.
van Boven, Michiel
author_sort Andeweg, Stijn P.
collection PubMed
description Respiratory syncytial virus (RSV) infection is a leading cause of hospitalization in infants. Underlying risk factors for RSV infection in the general population are not well understood, as previous work has focused on severe outcomes of infection in a clinical setting. Here we use RSV-specific IgG and IgA antibody measurements from two population-based cross-sectional serosurveys carried out in the Netherlands (n = 682) to classify children up to 5 years as seronegative or seropositive. We employ a generalized additive model to estimate the probability of prior RSV infection as function of age, date of birth within the year, and other risk factors. The analyses show that the majority of children have experienced a RSV infection before the age of 2 years. Age and birthdate are strong predictors of RSV infection in the first years of life, and children born in summer have higher estimated probability of infection than those born in winter [e.g., 0.56 (95% CI 0.45–0.66) vs. 0.32 (0.21–0.45) at age 1 year]. Our analyses reveal that the mean age at infection depends on date of birth, which has implications for the design of vaccination programmes and prioritisation schemes for the prophylactic use of monoclonal antibodies.
format Online
Article
Text
id pubmed-8076290
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80762902021-04-27 Population-based serology reveals risk factors for RSV infection in children younger than 5 years Andeweg, Stijn P. Schepp, Rutger M. van de Kassteele, Jan Mollema, Liesbeth Berbers, Guy A. M. van Boven, Michiel Sci Rep Article Respiratory syncytial virus (RSV) infection is a leading cause of hospitalization in infants. Underlying risk factors for RSV infection in the general population are not well understood, as previous work has focused on severe outcomes of infection in a clinical setting. Here we use RSV-specific IgG and IgA antibody measurements from two population-based cross-sectional serosurveys carried out in the Netherlands (n = 682) to classify children up to 5 years as seronegative or seropositive. We employ a generalized additive model to estimate the probability of prior RSV infection as function of age, date of birth within the year, and other risk factors. The analyses show that the majority of children have experienced a RSV infection before the age of 2 years. Age and birthdate are strong predictors of RSV infection in the first years of life, and children born in summer have higher estimated probability of infection than those born in winter [e.g., 0.56 (95% CI 0.45–0.66) vs. 0.32 (0.21–0.45) at age 1 year]. Our analyses reveal that the mean age at infection depends on date of birth, which has implications for the design of vaccination programmes and prioritisation schemes for the prophylactic use of monoclonal antibodies. Nature Publishing Group UK 2021-04-26 /pmc/articles/PMC8076290/ /pubmed/33903695 http://dx.doi.org/10.1038/s41598-021-88524-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Andeweg, Stijn P.
Schepp, Rutger M.
van de Kassteele, Jan
Mollema, Liesbeth
Berbers, Guy A. M.
van Boven, Michiel
Population-based serology reveals risk factors for RSV infection in children younger than 5 years
title Population-based serology reveals risk factors for RSV infection in children younger than 5 years
title_full Population-based serology reveals risk factors for RSV infection in children younger than 5 years
title_fullStr Population-based serology reveals risk factors for RSV infection in children younger than 5 years
title_full_unstemmed Population-based serology reveals risk factors for RSV infection in children younger than 5 years
title_short Population-based serology reveals risk factors for RSV infection in children younger than 5 years
title_sort population-based serology reveals risk factors for rsv infection in children younger than 5 years
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076290/
https://www.ncbi.nlm.nih.gov/pubmed/33903695
http://dx.doi.org/10.1038/s41598-021-88524-w
work_keys_str_mv AT andewegstijnp populationbasedserologyrevealsriskfactorsforrsvinfectioninchildrenyoungerthan5years
AT schepprutgerm populationbasedserologyrevealsriskfactorsforrsvinfectioninchildrenyoungerthan5years
AT vandekassteelejan populationbasedserologyrevealsriskfactorsforrsvinfectioninchildrenyoungerthan5years
AT mollemaliesbeth populationbasedserologyrevealsriskfactorsforrsvinfectioninchildrenyoungerthan5years
AT berbersguyam populationbasedserologyrevealsriskfactorsforrsvinfectioninchildrenyoungerthan5years
AT vanbovenmichiel populationbasedserologyrevealsriskfactorsforrsvinfectioninchildrenyoungerthan5years